Stay updated on Phase II Pembrolizumab Plus GVD Clinical Trial
Sign up to get notified when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.

Latest updates to the Phase II Pembrolizumab Plus GVD Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.0 was added. This change is a metadata/versioning update and does not alter the study details or how users interact with the page.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check54 days agoChange DetectedA minor site-wide revision (Revision: v3.4.2) was added, and the interim funding-status notice along with the previous revision entry (Revision: v3.4.1) were removed. There are no changes to study content or user interactions; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedAdded a site-wide notice regarding government funding and NIH Clinical Center status. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check68 days agoChange DetectedAdded a glossary display option and updated update-related metadata (including capitalization of 'Last Update Submitted that Met QC Criteria' and the 'Last Update Posted' label). The page revision is now v3.4.0, replacing v3.3.4.SummaryDifference0.2%

- Check82 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Phase II Pembrolizumab Plus GVD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.